@article {TuranP6.001作者={谭雅图兰和詹姆斯Meschia和珍妮弗Voeks和凯文·巴雷特和罗伯特·布朗和Seemant查图尔维迪马克Chimowitz和巴特Demaerschalk您正在Emmady和乔治·霍华德和弗吉尼亚霍华德和约翰·休斯顿和迈克尔·琼斯和Brajesh Lal和罗纳德·Lazar Moy韦斯利·摩尔和克劳迪娅和安娜Roldan称加里Roubin和托马斯·王硕},title ={风险因素控制和医生之间的关系专业Crest-2试验(P6.001)},体积={90}={15}补充数量,elocation-id = {P6.001} ={2018},出版商= {Wolters Kluwer健康,公司代表美国神经病学学会},文摘={目的:分析血管危险因素之间的关系控制在早期随访临床试验和医生特征评估无症状的颈动脉狭窄的优化管理。首页背景:在CREST2,密集的医疗管理的主题{\ textquoteright}血管危险因素是由网站的首席研究员(π)和由指定医疗管理实现医生(MMP)和协调员。这些医生有不同的专长和经验与风险因素的管理。我们试图确定风险因素之间的关系控制和PI和MMP的专业。设计/方法:613例至少1后续访问数据从105年CREST2网站被用于这些分析。CREST2网站分类基于π专业和MMP的专业。专业的site-designated主要MMP与多个MMP用于网站。我们比较患者的百分比目标在最后的随访中主要风险因素,低密度脂蛋白\ < 70 mg / dL和SBP \ < 140毫米汞柱,在π专业和MMP的专业中,使用卡方检验。结果:没有明显差异控制SBP或低密度脂蛋白π专业。有一个趋势之间的关联的低密度脂蛋白控制和MMP的专业,与较高的低密度脂蛋白控制站点与内科MMP的专家和较低的控制与血管手术基质金属蛋白酶。SBP在MMP的专业控制率没有显著差异。结论:早期分析风险因素控制在CREST2研究中,站点π和MMP的专业没有显著影响LDL和SBP在随访中。 This suggests that protocol care pathways are generalizable to diverse physicians.Disclosure: Dr. Turan has nothing to disclose. Dr. Meschia has nothing to disclose. Dr. Voeks has nothing to disclose. Dr. Barrett has nothing to disclose. Dr. Brown has nothing to disclose. Dr. Chaturvedi has received personal compensation in an editorial capacity for NEJM Journal Watch Neurology. Dr. Chaturvedi has received research support from Boehringer Ingelheim. Dr. Chimowitz has nothing to disclose. Dr. Demaerschalk has nothing to disclose. Dr. Emmady has nothing to disclose. Dr. Howard has nothing to disclose. Dr. Howard has nothing to disclose. Dr. Huston has nothing to disclose. Dr. Jones has nothing to disclose. Dr. Lal has nothing to disclose. Dr. Lazar has nothing to disclose. Dr. Moore has nothing to disclose. Dr. Moy has nothing to disclose. Dr. Roldan has nothing to disclose. Dr. Roubin has nothing to disclose. Dr. Brott has nothing to disclose.}, issn = {0028-3878}, URL = {//www.ez-admanager.com/content/90/15_Supplement/P6.001}, eprint = {//www.ez-admanager.com/content}, journal = {Neurology} }